EP2809336

FACTOR XII INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL INFLAMMATORY DISORDERS

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    31.1.2013
  • EP published:
    20.6.2018
  • EP application number:
    13701651.5
  • Max expiry date:
    30.1.2033
  • Title:
    FACTOR XII INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL INFLAMMATORY DISORDERS

Timeline

Today
31.1.2013EP application
20.6.2018EP Publication

Owner

  • Name:
    CSL Behring GmbH
  • Address:
    Emil-von-Behring-Strasse 76, 35041, Marburg, DE
  • Name:
    CSL Limited
  • Address:
    45 Poplar Road, 3052, Parkville VIC, AU
  • Name:
    Julius-Maximilians-Universitaet Wuerzburg
  • Address:
    Sanderring 2, 97070, Wuerzburg, DE
  • Name:
    Westfälische Wilhelms-Universität Münster
  • Address:
    Schlossplatz 2, 48149, Münster, DE

Inventor

  • Name:
    MEUTH, Sven
  • Address:
    Muenster, DE
  • Name:
    GOEBEL, Kerstin
  • Address:
    Pfaffenhausen, DE
  • Name:
    KLEINSCHNITZ, Christoph
  • Address:
    Heiligenhaus-Isenbuegel, DE
  • Name:
    MCKENZIE, Brent
  • Address:
    San MateoCA, US
  • Name:
    NOLTE, Marc
  • Address:
    Marburg, DE

Priority

  • Number:
    12153341
  • Date:
    31.1.2012
  • Country:
    EP
  • Number:
    201261592652 P
  • Date:
    31.1.2012
  • Country:
    US

Classification

  • Categories:
    A61K 38/06, A61K 38/48, A61K 38/55, A61K 38/57, A61K 39/395, A61K 47/50, C07K 14/81, C07K 16/36, C07K 16/40, A61P 25/00, A61P 37/00, A61K 38/17

Upload documents